In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or complementary to the existing interventions.

No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by sex, race and ethnicity, GLP-1 type, and diabetes status, as well as over a range of follow-up times up to 3 years, they noted in JAMA Pediatrics.

Concerns that the new GLP-1 weight-loss meds might raise suicide risks in adolescents may be eased by the results of new research The study of more than 54,000 kids found no rise in risk, and a 33% decline in risk for suicidal thoughts in obese teens taking the meds Get any of our free email newsletters — news headlines,

GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 diabetes by slowing digestion and causing someone to